• Facebook
  • X
  • Instagram
MYELOMA360
  • Home
  • Myinsights
  • MYBoard
  • Strategy & Consulting
Select Page

Rebuilding Resilience: Navigating Aging and Exercise After CLL

by MM360 Staff | May 28, 2025 | Uncategorized

Source: CureToday articles After running the Boston Marathon at 67, I faced new limits from aging and chronic lymphocytic leukemia — but I’ve found ways to stay strong and resilient. Read More

Phase 1/2 Trial Investigating ATR-04 for EGFRi-Related Rashes in Lung Cancer

by MM360 Staff | May 28, 2025 | Uncategorized

Source: CureToday articles ATR-04 therapy is being investigated in the phase 1/2 ATR04-484 clinical trial for the treatment of EGFR inhibitor-associated rashes in lung cancer. Read More

Neoadjuvant Efti/Keytruda Combo Improves Tumor Fibrosis Rates in Sarcoma

by MM360 Staff | May 28, 2025 | Uncategorized

Source: CureToday articles Neoadjuvant efti and Keytruda plus radiotherapy met the EFTISARC-NEO trial’s primary end point by improving tumor fibrosis in soft tissue sarcoma. Read More

Radiation Therapy Eases Symptoms and Improves Targeting in Lung Cancer

by MM360 Staff | May 28, 2025 | Uncategorized

Source: CureToday articles Radiation therapy can treat lung cancer at all stages, easing symptoms, improving precision and minimizing side effects with modern techniques. Read More

The Dawn of AI in Prostate Cancer Care

by MM360 Staff | May 27, 2025 | Uncategorized

Source: CureToday articles A powerful new ally is emerging in cancer care: artificial intelligence. Read More

Gene Variant May Predict Side Effects From Kidney Cancer Immunotherapy

by MM360 Staff | May 27, 2025 | Uncategorized

Source: CureToday articles A variant in the IL-7 gene may predict which patients with kidney cancer are more likely to experience side effects from immunotherapy. Read More
« Older Entries
Next Entries »

Recent Content

  • Utilizing AI in Prostate Cancer Care and Management
  • KITE-363 Shows High Response in B-Cell Lymphoma With Manageable Safety
  • Rilonacept in Recurrent Pericarditis: Mechanism of Action, Patient Management, and Clinical Considerations
  • Zyprexa Added to Standard Antiemetics Reduces Nausea, Vomiting in Radiation
  • Op-Ed: Expand Patient Choice to Lower Medication Costs
  • Sasanlimab-BCG Combo May Delay Recurrence in Bladder Cancer
  • Meta-Analysis Evaluates RSV Viral Load and Symptom Kinetics
  • Personalized Vaccine Elicits Responses in Patients With Kidney Cancer
  • SCIg More Effective Immunoglobulin Option for Immunocompromised Patients With Inborn Errors of Immunity
  • GLP-1 Receptor Agonists Demonstrate Increased Risk of Neovascular Age-Related Macular Degeneration in Diabetes
  • Facebook
  • X
  • Instagram
©2016-2025 MYELOMA360 & Connect BioMed
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Do not sell my personal information.
SettingsAccept
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT